Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Menopause can cause skin issues, and seeing a dermatologist helps.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

FFA and FAPD might be related or stages of the same disease.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Facial trichostasis spinulosa is a chronic condition with significant cosmetic impact, especially in young women.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

No cure exists for alopecia areata, and treatments are personalized.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.